HydroxygenkwaninCAS# 20243-59-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 20243-59-8 | SDF | Download SDF |
| PubChem ID | 5318214 | Appearance | Yellow-brownish powder |
| Formula | C16H12O6 | M.Wt | 300.3 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Synonyms | 7-O-Methylluteolin | ||
| Solubility | Soluble in methan | ||
| Chemical Name | 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxychromen-4-one | ||
| SMILES | COC1=CC(=C2C(=C1)OC(=CC2=O)C3=CC(=C(C=C3)O)O)O | ||
| Standard InChIKey | RRRSSAVLTCVNIQ-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C16H12O6/c1-21-9-5-12(19)16-13(20)7-14(22-15(16)6-9)8-2-3-10(17)11(18)4-8/h2-7,17-19H,1H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Hydroxygenkwanin has cytotoxicity, may be an effective natural product to treat glioma, and the combination of Apigenin and Hydroxygenkwanin may be a promising method for glioma chemotherapy. |
| Targets | TNF-α | Caspase | BID | BAK | BCL-XL |
| In vitro | Synergistic anti-glioma effect of Hydroxygenkwanin and Apigenin in vitro.[Pubmed: 24144774]Chem Biol Interact. 2013 Nov 25;206(2):346-55.Apigenin (AP) and Hydroxygenkwanin (HGK) are two natural flavonoid compounds. Previous studies have already demonstrated the anti-tumor capability of AP. However, it is not clear whether Hydroxygenkwanin has such property. |
Hydroxygenkwanin Dilution Calculator
Hydroxygenkwanin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.33 mL | 16.65 mL | 33.3 mL | 66.6001 mL | 83.2501 mL |
| 5 mM | 0.666 mL | 3.33 mL | 6.66 mL | 13.32 mL | 16.65 mL |
| 10 mM | 0.333 mL | 1.665 mL | 3.33 mL | 6.66 mL | 8.325 mL |
| 50 mM | 0.0666 mL | 0.333 mL | 0.666 mL | 1.332 mL | 1.665 mL |
| 100 mM | 0.0333 mL | 0.1665 mL | 0.333 mL | 0.666 mL | 0.8325 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Etoricoxib
Catalog No.:BCC1565
CAS No.:202409-33-4
- 2,2-Bis(4-chloroformyloxyphenyl)propane
Catalog No.:BCC8491
CAS No.:2024-88-6
- Scillascilloside B-1
Catalog No.:BCN6998
CAS No.:2023822-41-3
- Scillascillone
Catalog No.:BCN6992
CAS No.:2023822-40-2
- Scillascillol
Catalog No.:BCN7008
CAS No.:2023822-39-9
- PNU-159682
Catalog No.:BCC5463
CAS No.:202350-68-3
- Dasycarpol
Catalog No.:BCN7134
CAS No.:202343-57-5
- Dregeoside Aa1
Catalog No.:BCN4678
CAS No.:20230-41-5
- Spiraeoside
Catalog No.:BCC8251
CAS No.:20229-56-5
- Flucytosine
Catalog No.:BCC3780
CAS No.:2022-85-7
- Spiperone hydrochloride
Catalog No.:BCC6882
CAS No.:2022-29-9
- Bilastine
Catalog No.:BCC5263
CAS No.:202189-78-4
- 1,3,7-Trihydroxy-2-prenylxanthone
Catalog No.:BCN4886
CAS No.:20245-39-0
- AM 281
Catalog No.:BCC6944
CAS No.:202463-68-1
- Ro 04-6790
Catalog No.:BCC7512
CAS No.:202466-68-0
- Glomeratose A
Catalog No.:BCN8400
CAS No.:202471-84-9
- JANEX-1
Catalog No.:BCC1668
CAS No.:202475-60-3
- 13(18)-Oleanen-3-one
Catalog No.:BCN4887
CAS No.:20248-08-2
- 13-O-Ethylpiptocarphol
Catalog No.:BCN7448
CAS No.:202522-40-5
- OTX-015
Catalog No.:BCC1829
CAS No.:202590-98-5
- Calyxin H
Catalog No.:BCN4888
CAS No.:202596-22-3
- H-Valinol
Catalog No.:BCC2696
CAS No.:2026-48-4
- Ginkgolic acid C13:0
Catalog No.:BCN5333
CAS No.:20261-38-5
- DL-AP3
Catalog No.:BCC2459
CAS No.:20263-06-3
Synergistic anti-glioma effect of Hydroxygenkwanin and Apigenin in vitro.[Pubmed:24144774]
Chem Biol Interact. 2013 Nov 25;206(2):346-55.
Apigenin (AP) and Hydroxygenkwanin (HGK) are two natural flavonoid compounds. Previous studies have already demonstrated the anti-tumor capability of AP. However, it is not clear whether HGK has such property. In the current study, the anti-glioma activities of HGK and its synergistic anti-glioma effects with AP on C6 glioma cells were investigated. In addition, the possible mechanisms were also studied. MTT assay and morphologic analysis including acridine orange/ethidium bromide (AO/EB) and 4',6-diamidino-2-phenylindole (DAPI) staining were used in the research, and the results indicated that the treatment with AP or HGK could inhibit C6 glioma cell proliferation respectively. Moreover, when AP was administrated simultaneously, the anti-glioma effect of HGK was dramatically enhanced in a dose-dependent manner, which is obviously better than that of carmustine (BCNU) at the concentration 25muM for treating of 24h. Compared with control, mitochondrial membrane potential (MPP) loss and mitochondrion damage were detected by JC-1 fluorescence probes (JC-1) and transmission electron microscopy (TEM) after treatment. Obvious DNA damage and cell cycle S phase arrest were detected by alkaline comet assay and flow cytometric analysis (FCM). Additionally, up regulation of TNF-alpha level, activations of caspase-3, -8, over expressions of BID and BAK protein and BCL-XL protein down expression were also observed after treatment by the combination of AP and HGK. The results indicate that HGK may be an effective natural product to treat glioma, and the combination of AP and HGK may be a promising method for glioma chemotherapy.
